Macrophages are important source of PD-L1 and PD-L1 expressing in macrophages affect the prognosis of NSCLC patients with tumor PD-L1 negative

被引：0
|
作者：
Liu, Y. [1 ]
Cao, L. [1 ]
Che, X. [1 ]
Qiu, X. [2 ]
Li, Z. [1 ]
Yang, B. [1 ]
Wang, S. [1 ]
Qu, X. [1 ]
机构：
[1] China Med Univ, Hosp 1, Dept Med Oncol, Shenyang, Liaoning, Peoples R China
[2] China Med Univ, Dept Pathol, Coll Basic Med Sci, Shenyang, Liaoning, Peoples R China
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2019年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P1920
引用
收藏
页码：531 / 532
页数：2
相关论文
共 50 条
  • [21] PD-L1 Amino Acid Position 88 Represents a Hotspot for PD-L1 Stability With Relevance for PD-L1 Inhibition
    Claass, Luise Victoria
    Schultheiss, Christoph
    Scholz, Rebekka
    Paschold, Lisa
    Simnica, Donjete
    Heinemann, Volker
    Stintzing, Sebastian
    Binder, Mascha
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [22] Impact of PD-L1 feedback modulation on the sensitivity of anti-PD-1/PD-L1
    Zhu, Jian
    Zhu, Rebecca L.
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [23] Comparison of PD-L1 Immunohistochemistry Assays and Response to PD-L1 Inhibitors
    Dacic, S.
    Ancevski, K.
    Aberrbock, S.
    Herbst, C.
    Villaruz, L.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2115 - S2115
  • [24] PD-L1 blockade efficacy relies on host cell PD-L1
    Brownell, I.
    Udey, M.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (05) : 1000 - 1000
  • [25] Determination of PD-L1 positive CETCs as a biomarker for PD-1/PD-L1 treatment monitoring
    Pizon, M.
    Schott, D.
    Pachmann, U.
    Pachmann, K.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 89 - 89
  • [26] PD-L1 on host cells is essential for PD-L1 blockade-mediated tumor regression
    Tang, Haidong
    Liang, Yong
    Anders, Robert A.
    Taube, Janis M.
    Qiu, Xiangyan
    Mulgaonkar, Aditi
    Liu, Xin
    Harrington, Susan M.
    Guo, Jingya
    Xin, Yangchun
    Xiong, Yahong
    Nham, Kien
    Silvers, William
    Hao, Guiyang
    Sun, Xiankai
    Chen, Mingyi
    Hannan, Raquibul
    Qiao, Jian
    Dong, Haidong
    Peng, Hua
    Fu, Yang-Xin
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2018, 128 (02): : 580 - 588
  • [27] Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
    Diggs, Laurence P.
    Hsueh, Eddy C.
    [J]. BIOMARKER RESEARCH, 2017, 5
  • [28] Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
    Laurence P. Diggs
    Eddy C. Hsueh
    [J]. Biomarker Research, 5
  • [29] Highly Activated PD-1/PD-L1 Pathway in Gastric Cancer with PD-L1 Expression
    Saito, Hiroaki
    Kono, Yusuke
    Murakami, Yuki
    Shishido, Yuji
    Kuroda, Hirohiko
    Matsunaga, Tomoyuki
    Fukumoto, Yoji
    Osaki, Tomohiro
    Ashida, Keigo
    Fujiwara, Yoshiyuki
    [J]. ANTICANCER RESEARCH, 2018, 38 (01) : 107 - 112
  • [30] PD-L1 Expression is Related to Tumor Staging in NSCLC
    Wang, Hangjun
    Agulnik, Jason
    Kasymjanova, Goulnar
    Wang, Anna Y.
    Cohen, Victor
    Small, David
    Pepe, Carmela
    Sakr, Lama
    Fiset, Pierre O.
    Auger, Manon
    Camilleri-Broet, Sophie
    Alameldin, Mona
    Chong, George
    van Kempen, Leon
    Spatz, Alan
    [J]. LABORATORY INVESTIGATION, 2018, 98 : 755 - 755
12345